Page 24 - 分子轉譯影像中心季刊X

圖五、 C-PBB3在AD病患與正常健康人的海馬迴(白色箭頭)相比，差異非常明
11
11
11
顯，AD病患海馬迴腦區的 C-PBB3表現較高，且在更嚴重的AD患者 C-PBB3
會更加累積在皮質區，相反的，Aβ PET正子放射性示蹤劑， C-PiB卻沒有如此
11
明顯的差異。

參考文獻：
1. Villemagne VL, Doré V, Burnham SC, Masters CL, Rowe CC. Imaging tau and
amyloid-β proteinopathies in Alzheimer disease and other conditions.Nat Rev
Neurol.2018 Feb 16.
2. Ruiqing Ni, Bin Ji, Maiko Ono, Naruhiko Sahara, Ming-Rong Zhang, Ichio Aoki,
Agneta Nordberg, Tetsuya Suhara and Makoto Higuchi. Comparative in-vitro and
in-vivo quantifications of pathological tau deposits and their association with
neurodegeneration in tauopathy mouse models. J Nucl Med. 2018 Feb 1.
3. C.Foguem, B.Kamsu-Foguem. Revue Neurologique(Paris).2016 Nov;172(11):709-
714.
4. Maruyama M1, Shimada H, Suhara T, Shinotoh H, Ji B, Maeda J, Zhang MR,
Trojanowski JQ, Lee VM, Ono M, Masamoto K, Takano H, Sahara N, Iwata N,
Okamura N, Furumoto S, Kudo Y, Chang Q, Saido TC, Takashima A, Lewis J, Jang MK,
Aoki I, Ito H, Higuchi M. Imaging of tau pathology in a tauopathy mouse model and
in Alzheimer patients compared to normal controls. Neuron. 2013 Sep
18;79(6):1094-108.
5. Villemagne VL, Fodero-Tavoletti MT, Masters CL, Rowe CC. Tau imaging: early
progress and future directions. Lancet Neurol. 2015 Jan;14(1):114-24.